InsidersTradesSigma
Track the ODI Pharma AB (publ) stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, ODI Pharma AB (publ) has logged 1 reports. Market capitalisation: €44m. The latest transaction was reported on 15 January 2026 (Purchase). Among the most active insiders: Johan Edewaard. Every trade is openly available.
1
Insider Decl.
n/a
Thresholds
€3,502
1 ops.
Buy Volume
n/a
n/a
Sell Volume
31Σ signal
Fundamental score
Ranked 26,578 of 29,063 companies
20.3
score / 100
Value16
Quality24
FCF yld-7.5%
Earn yld-13%
EV/EBITDA·
ROE-28%
Gross mgn27%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 January 2026
Declarations1 total
10,000 shares@ €0.35020.0049% mcap100.0% of flowAktieISIN SE0013409760FI:A003V318-1
1 of 1 declaration
Acerca de ODI Pharma AB (publ)
ODI Pharma AB (publ) es una empresa farmacéutica sueca que cotiza en la Bolsa de Estocolmo. Se centra en el desarrollo de tratamientos innovadores en el sector de la salud.